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Peripartum cardiomyopathy (PPCM) is an idiopathic cardiomyopathy presenting with acute
heart failure during the peripartum period. It is common in patients of African ancestry. Cur-
rently, there is paucity of data on the burden, predictors and outcomes of PPCM in Uganda.
This study aimed to investigate the prevalence, predictors and six-month outcomes of
PPCM in an adult cohort attending a tertiary specialised cardiology centre in Kampala,
Uganda.
Methods
This study consecutively enrolled 236 women presenting with features of acute heart failure
in the peripartum period. Clinical evaluation and echocardiography were performed on all
the enrolled women. PCCM was defined according to recommendations of the Heart Failure
Association of the European Society of Cardiology Working Group on PPCM. Poor outcome
at six months of follow-up was defined as presence of any of the following: death of a mother
or her baby, New York Heart Association (NYHA) functional class III-IV or failure to achieve
complete recovery of left ventricular function (left ventricular ejection fraction�55%).
Results
The median age, BMI and parity of the study participants was 31.5 (25.5–38.0) years, 28.3
(26.4–29.7) and 3 (2–4) respectively. The prevalence of PPCM was 17.4% (n = 41/236).
Multiple pregnancy was the only predictor of PPCM in this study population (OR 4.3 95% CI
1.16–16.05, p = 0.029). Poor outcome at six-months was observed in about 54% of the
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patients with PPCM (n = 4, 9.8% in NYHA functional class III-IV and n = 22, 53.7% with
LVEF <55%). No maternal or foetal mortality was documented.
Conclusion
PPCM is relatively common in Uganda and is associated with multiple pregnancy. Poor out-
comes especially absence of complete recovery of left ventricular function are also com-
mon. Large studies to further investigate long-term maternal and foetal outcomes in Uganda
are justified.
Introduction
Peripartum cardiomyopathy (PPCM) is an idiopathic cardiomyopathy presenting with acute
heart failure following left ventricular (LV) systolic dysfunction towards the last months of
pregnancy or few months post-delivery. It is a diagnosis of exclusion and the left ventricular
ejection fraction (LVEF) is invariably <45% [1, 2].
PPCM has been documented to occur more commonly in women of African descent and is
associated with poor outcomes [3–5]. Despite being a common cause of acute heart failure
with reduced ejection fraction (EF) and associated devastating clinical outcomes in African
women, there is limited published data about its burden, predictors and maternal or foetal out-
comes in black African women outside Western and Southern Africa. The majority of pub-
lished studies are from Nigeria [6–15] and South Africa [16–21].
Basing on hospital based studies, the incidence of PPCM in Africa is estimated to be 1 in
1000 live births in South Africa [20], about 1 in 96–2,700 deliveries in Nigeria [7, 8, 11] and 1
in 3,800 deliveries in Burkina Faso [22]. The prevalence of PPCM ranges between 4.1%-13.9%
[12, 13, 23–25]. The reasons for this wide disparity in burden of PPCM in SSA has not been
extensively studied but may be related to genetic and environmental differences.
The above studies have also demonstrated that PPCM is associated with poor maternal out-
comes in African patients like high rates of maternal mortality, incomplete recovery of LV
function and minimal improvement in New York Heart Association (NYHA) functional class
after six to twelve months of follow-up [11, 17–19, 21, 22, 26].
Despite PPCM being frequently encountered in clinical care in Uganda, we lack contempo-
rary information about its burden, predictors and related maternal or foetal outcomes. This
study aimed to determine the prevalence of PPCM, its related predictors and six-month mater-
nal and foetal outcomes in a cohort of women attending the adult cardiology clinic at Uganda
Heart Institute, a tertiary specialised cardiology centre in Uganda.
Materials and methods
Study site and period
This study was conducted at the Uganda Heart Institute (UHI), Kampala Uganda. The UHI is
an autonomous public tertiary institution that offers specialised paediatric and adult medical
and surgical cardiology services. The UHI is part of the Mulago National Referral and Teach-
ing Hospital Kampala, Uganda which is the main national referral hospital in Uganda offering
tertiary specialty medical services with a bed capacity of 1,500.
The study was conducted from September 2018 to June 2019.
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Study design
This was a prospective study with a six-month follow-up period of all mothers with confirmed
PPCM, to identify the pre-defined maternal and foetal outcomes of interest.
Study eligibility
We included any woman referred from the different maternity health facilities who was
�18 years presenting with symptoms of congestive cardiac failure that developed in the last
month of pregnancy or during the first five months postpartum, without any identifiable
cause for heart failure like coronary artery disease, pre-existing hypertension, rheumatic
heart disease and congenital heart disease and offered written informed consent to partici-
pate in the study.
We excluded peripartum mothers with systolic blood pressure >160 or <95 mm Hg or dia-
stolic >105 mm Hg, clinical conditions other than cardiomyopathy, significant liver disease
(defined as liver transaminase levels >2 times the upper limit of normal), impaired renal func-
tion (defined as urea and/or creatinine >1.5 times the upper limit of normal) and pre-existing
clinical conditions like ischemic heart disease, rheumatic heart disease, malignancy, congenital
heart disease and known cardiomyopathies.
Data collection
A pre-tested study questionnaire was used to collect all the significant socio-demographic,
clinical and laboratory data of all the study participants. An electrocardiography (ECG) and
echocardiography (ECHO) were performed on each study participant using standard criteria
and methods.
PPCM was defined according to the Working Group on PPCM of the Heart Failure Associ-
ation (HFA) of the European Society of Cardiology (ESC) recommendation of: an idiopathic
cardiomyopathy presenting with heart failure secondary to LV systolic dysfunction (LVEF
<45%) towards the end of pregnancy or in the months following delivery, if no other cause of
heart failure is found [2]. Information about other echocardiographic variables like dimen-
sions of the inter-ventricular septum (IVS), LV diameter in diastole (LVd), LV diameter in sys-
tole (LVs), left atrium (LA), right ventricle diameter in diastole (RVd), left ventricular post
wall diameter in diastole (LVPWd) and mitral valve E:A ratio were also obtained. An ECG was
performed to document presence or absence of left bundle branch block (LBBB).
A detailed clinical examination was also performed for assessment of pallor of mucous
membranes, pedal oedema, jugular venous distension, hepatomegaly, pulmonary rales and
heart sounds.
After the physical examination and completion of the ECG and ECHO, each study partici-
pant with confirmed PPCM received health education about the medical condition and stan-
dard heart failure regimen. The latter was an angiotensin converting enzyme inhibitor (ACEI)
or angiotensin II receptor blocker (ARB), a loop diuretic, an aldosterone antagonist (spirono-
lactone) and a beta blocker for those in the postpartum period while those in the last month of
pregnancy received only a loop diuretic and a beta blocker. Digoxin was prescribed only for
mothers with atrial fibrillation.
A six-month follow-up visit was scheduled mainly for a clinical review to re-evaluate the
NYHA functional class, to perform a repeat ECHO to assess change in LVEF and to document
the maternal and foetal outcomes. Poor outcomes were death of the mother and/or her baby,
mothers in NHYA functional class III and IV and incomplete recovery of LV function (LVEF
�55%).
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Statistical analysis
Proportions and medians with interquartile ranges (IQR) were used to summarise the socio-
demographic, clinical, laboratory, ECG and ECHO characteristics, as appropriate. Chi-square,
Fisher’s test, Student’s t and Mann–Whitney tests were used to compare categorical and con-
tinuous variables, as appropriate. Both univariate analyses and multivariate logistic regression
were performed to identify independent predictors of PPCM. All values were expressed with
odds ratio (OR) and 95% confidence intervals (CI). A p value of<0.05 and a 95% CI not con-
taining 1 were considered of statistical significance.
Ethics approval
This study was approved by the School of Medicine Research and Ethics Committee Makerere
University and the Uganda National Council for Science and Technology (UNCST). All study
participants were treated according to the declaration of Helsinki and offered a written
informed consent to participate in the study.
Results
Prevalence of PPCM among women presenting with acute heart failure in
the peri-partum period
The median age, body mass index (BMI) and parity of the study participants was 31.5 (25.5–
38.0) years, 28.3 (26.4–29.7) and 3 (2–4) respectively with about 9% of the study participants
having a multiple pregnancy. PPCM was confirmed in 41 study participants, giving a preva-
lence of 17.4%.
Socio-demographic characteristics of the study participants
The socio-demographic characteristics of the study participants are shown in Table 1.
Compared to study participants without PPCM, patients with PPCM were more likely to
have a multiple pregnancy (21.9% Vs 6.3%, p = 0.004), to have a history of cardiomyopathy in
the past pregnancy (7.3% Vs 1.1%, p = 0.040) and were less unemployed (29.3% Vs 38.2%,
p = 0.027). Among the study participants, only one had confirmed pre-eclampsia but without
PPCM.
Laboratory and ECHO characteristics of the study participants
The laboratory and ECHO characteristics of the study participants are shown in Table 2.
Patients with confirmed PPCM had significantly lower median serum alanine transaminase
(ALT), creatinine, urea and sodium levels compared to those without PPCM. Considering the
ECHO findings, patients with PPCM had significantly higher median values of RVd, LVd, LVs
and a lower median LVPWD.
Factors associated with PPCM
On multivariate regression, multiple pregnancy (OR 4.3 95% CI 1.16–16.05, p = 0.029) was the
only independent predictor of PPCM in this study population.
Outcomes among patients with confirmed PPCM at six-months of follow-
up
Poor outcomes defined as presence of either: maternal death, NYHA functional class III and
IV or incomplete recovery of LV function (EF�55%) were observed in 22 (53.7%) patients.
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Table 1. Baseline socio-demographic and clinical characteristics of the study participants.
Variable Median (IQR) Confirmed PCCM PCCM Absent P-value
(n = 41, 17.4%) (195, 82.6%) Median (IQR)
Median (IQR)
Age, years 31.5 (25.5–38) 35 (27–39) 31 (25–38) 0.084
Parity 3 (2–4) 3 (2–6) 3 (2–4) 1.000
Weeks into pregnancy or postpartum 9 (7–13) 8 (6–14) 10 (7–13) 0.024
Body mass index in kg/m2 28.3 (26.4–29.7) 27.7 (26–29.7) 28.6 (26.4–29.8) 0.188
Variable N (%) Confirmed PCCM PCCM Absent P-value
(EF <45%) N (%) (EF� 45%) N (%)
Age, years
18–35 137 (62.0) 21 (53.9) 116 (63.7)
>35 84 (38.0) 18 (46.1) 66 (36.3) 0.248
Parity
1 45 (19.4) 9 (21.9) 36 (18.9)
2–4 140 (60.3) 21 (51.2) 119 (62.3)
�5 47 (20.3) 11 (26.8) 36 (18.9) 0.384
Occupation
Un-employed 85 (36.6) 12 (29.3) 73 (38.2)
Self -employed 69 (29.7) 14 (34.1) 55 (28.8)
Unskilled 9 (3.88) 1 (2.4) 8 (4.2)
Professional 21 (9.05) 9 (22.0) 12 (6.3)
Skilled 48 (20.7) 5 (12.2) 43 (22.5) 0.027
Education level
No formal education 22 (9.5) 1 (2.4) 21 (11.0)
Primary 80 (34.5) 14 (34.2) 66 (34.6)
Secondary 69 (29.7) 9 (21.9) 60 (31.4)
Tertiary 61 (26.3) 17 (41.5) 44 (23.0) 0.055
Smoking
No 228 (98.3) 39 (95.1) 189 (98.9)
Yes 4 (1.7) 2 (4.9) 2 (1.1) 0.145
Alcohol consumption
No 204 (87.9) 35 (85.4) 169 (88.5)
Yes 28 (12.1) 6 (14.6) 22 (11.5) 0.599
Multiple pregnancy
Yes 21 (9.1) 9 (21.9) 12 (6.3)
No 210 (90.9) 32 (78.1) 178 (93.7) 0.004
Diabetes
No 229 (98.7) 40 (97.6) 189 (98.9)
Yes 3 (1.3) 1 (2.4) 2 (1.1) 0.444
Cardiomyopathy in past pregnancy
No 227 (97.8) 38 (92.7) 189 (98.9)
Yes 5 (2.2) 3 (7.3) 2 (1.1) 0.040
Family history of heart disease.
No 195 (84.1) 38 (92.7) 157 (82.2)
Yes 37 (15.9) 3 (7.3) 34 (17.8) 0.106
Pre-eclampsia
No 231(99.6) 41(100.0) 190(99.5)
Yes 1(0.4) 0(0.0) 1(0.5) 1.000
(Continued)
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Individually, four (9.8%) patients were in NYHA functional class III and IV and 22 (53.7%)
patients had incomplete recovery of LV function at six-month follow-up period. Full recovery
of the left ventricular function occurred in 19 (46.3%) patients. No maternal or foetal mortality
was documented at the six-month follow-up time point.
The changes in the NYHA functional class between baseline and at six months of follow-up
are shown in Fig 1.
Discussion
To our knowledge, this is the first study to robustly investigate the burden, predictors and
short-term outcomes of PPCM in Uganda and Eastern Africa at large.
The reported study prevalence of PPCM of 17.4% among peripartum women is almost
comparable to what has been reported in a study in South Africa (13.8%) [25] and Nigeria
(13.9%) [13]. A lower prevalence of PPCM was reported in patients presenting with acute
heart failure in a tertiary hospital in Botswana (4.1%) [23] and in adults patients referred for
ECHO in rural Tanzania (7%) [24]. Another study conducted in Nigeria also reported a low
prevalence of PPCM of 4.2%, which accounted for 52.4% of all ECHO confirmed diagnosis of
cardiomyopathies [12].
Our study also demonstrated that the majority of the patients with PPCM had mild disease
severity and a low prevalence of self-reported co-morbidities. About 31.7% (n = 13) of patients
Table 1. (Continued)
HIV Status
Negative 173 (74.6) 29 (70.7) 144 (75.4)
Positive 59 (25.4) 12 (29.3) 47 (24.6) 0.534
Body mass index, kg m2
<25 27 (12.1) 7 (18.4) 20 (10.8)
25–29 149 (66.5) 25 (65.8) 124 (66.7)
�30 48 (21.4) 6 (15.8) 42 (22.6) 0.329
Signs of heart failure
Pedal oedema
No 125 (53.8) 16 (39.0) 109 (57.1)
Yes 107 (46.1) 25 (61.0) 82 (42.9) 0.035
Bibasilar crepitation
No 101 (43.5) 17 (41.5) 84 (44.0)
Yes 131 (56.5) 24 (58.54) 107 (56.0) 0.768
Hepatomegaly
No 224 (96.5) 34 (82.9) 190 (99.5)
Yes 8 (3.5) 7 (17.1) 1 (0.5) <0.001
NYHA Class (1-1V)
I 75 (33.2) 10 (24.4) 65 (35.1)
II 100 (44.3) 18 (43.9) 82 (44.3)
III 49 (21.7) 11 (26.8) 38 (20.5)
IV 2 (0.9) 2 (4.9) 0 (0.0) 0.013
ECG findings
LBBB Absent 136 (59.7) 21 (56.8) 115 (60.2)
LBBB Present 92 (40.4) 16 (43.2) 76 (39.8) 0.695
NYHA- New York Heart Association, ECG- Electrocardiography, LBBB- Left bundle branch block.
https://doi.org/10.1371/journal.pone.0240837.t001
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Table 2. Laboratory and echocardiographic characteristics of the study participants.
Confirmed PCCM PCCM Absent
(n = 41, 17.4%) (n = 195, 82.6%)
Variable Median IQR Median (IQR) Median (IQR) P-value
Laboratory characteristics
Albumin 40 (34–45) 40 (34–45) 40 (34–45) 0.338
ALT 47 (43–49) 44 (36–47) 47 (43–49) 0.004
AST 39 (36–46) 37 (33–43) 39 (37–46) 0.255
Creatinine 107 (99–112) 99 (88–109) 108 (99–112) 0.001
Urea 6.2 (5.1–6.9) 5.3 (3.9–7) 6.3 (5.3–6.9) 0.009
Serum sodium 141 (139–143.5) 140 (138–143) 142 (139–144) 0.010
Serum potassium 4.9 (4.5–5.2) 4.8 (4.5–5) 5 (4.5–5.3) 0.115
Random blood glucose 5.5 (4.8–6) 5.4 (4.9–5.9) 5.6 (4.8–6.1) 0.668
Echocardiographic findings
RVd 2.7 (2.4–3) 3 (2.5–3.5) 2.7 (2.4–2.9) <0.001
LVd 4.5 (4.1–5) 6.1 (5.3–6.5) 4.4 (4.1–4.8) <0.001
LVs 2.8 (2.5–3.2) 4.8 (3.2–5.4) 2.7 (2.5–3) <0.001
EA 1.2 (1–1.4) 1.4 (1–1.6) 1.2 (1–1.4) 0.055
IVSd 0.9 (0.8–1.0) 0.9 (0.7–0.9) 0.9 (0.8–1) 1.000
LVPWd 0.9 (0.7–0.9) 0.8 (0.7–0.9) 0.9 (0.8–1) <0.001
LA 3.4 (3.1–3.8) 3.4 (3.1–3.7) 3.4 (3.1–3.7) <0.001
ALT- Alanine transaminase, AST- Aspartate transaminase, RVd- Right ventricle diameter in diastole, LVd- Left ventricle diameter in diastole, LVs- Left ventricle
diameter in systole, IVSd- Interventricular septal diameter in diastole, LVPWd- Left ventricle posterior wall diameter in diastole, LA- Left atrial diameter.
https://doi.org/10.1371/journal.pone.0240837.t002
Fig 1. Changes in the New York Heart Association (NYHA) functional class in mothers with PPCM.
https://doi.org/10.1371/journal.pone.0240837.g001
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with PPCM presented in NYHA class III/IV in our cohort. This finding of mild disease sever-
ity in our study cohort starkly contrasts with what has been observed in other African studies.
Studies conducted in Zimbabwe [26], Togo [27] and South Africa [17, 18, 21] reported about
46.5%, 77% and 66.7–89% of patients with PPCM presenting in NYHA functional class III/IV
at baseline respectively. A high proportion of patients with PPCM presenting in NYHA func-
tional class III or IV (68.8%) was also reported by a multi-country study investigating clinical
characteristics of patients with PPCM in Africa, Middle East, Asia and Europe [28].
A self-reported diagnosis of diabetes mellitus and HIV infection was noted in 2.4% and
29.3% of the patients with PPCM respectively in our study cohort. Two studies conducted in
South Africa reported varying prevalence of HIV of 10% [21] and 34% [18] in patients with
PPCM.
No patient with PPCM in our study cohort was diagnosed with a thromboembolic event as
part of the co-morbidities at baseline. PPCM is one of the recognised clinical causes of
thrombo-embolic phenomenon in young women due to the related hypercoagulable state,
venous stasis and diffuse vascular damage [29].
About 6.4% of patients with PPCM in the Peripartum Cardiomyopathy in Nigeria
(PEACE) registry had an intra-cardiac thrombus on ECHO [8]. A comparable proportion of
patients in thes
EURObservational Research Programme (EORP), an ongoing registry for patients with
PPCM presented with thrombo-embolic events (6.8%) [28]. A higher prevalence of co-existing
intra-cardiac thrombus of 9.3% and 16.7% was documented in a study in Zimbabwe [26] and
South Africa respectively [21]. Thrombo-embolic events are also associated with a high risk of
mortality. In a study conducted in Zimbabwe, deep vein thrombosis and an intra-mural
thrombosis were presumed to be one of the direct causes of death in three patients with PPCM
within 3 months of follow-up [26].
Multiple pregnancy was the only identified independent predictor of PPCM in our study
population. It increased the odds of developing PPCM by 4-fold. PPCM occurs frequently in
cases of multiple gestation status. According to one systematic review and meta-analysis, 9% of
PPCM cases had multiple pregnancy [30].
Multiple pregnancy is associated with increased placental secretion of an anti-angiogenic
factor called soluble fms-like tyrosine kinase-1 (sFlt-1) which causes wide-spread endothelial
dysfunction and cardiac dysfunction [31].
There is limited data about predictors of PPCM in black African populations. The PEACE
registry in Nigeria of 406 patients with PPCM identified lack of formal education, under-
weight, unemployment status, and pre-eclampsia as predictors of PPCM. The greatest associa-
tion with PPCM was noted with underweight and pre-eclampsia which increased the odds of
PPCM by 12- and 10-fold respectively. Lack of formal education and unemployed status
increased the odds by 2- and 3 folds respectively [8].
At six months of follow-up, 53.7% of mothers in this study had incomplete recovery of LV
function and 9.8% were in NYHA functional class III or IV. There was no documented mater-
nal or foetal mortality in this study cohort.
There are several plausible explanations for these outcomes. A small proportion of mothers
with PPCM presented in NYHA functional class III/IV (31.7%) at baseline which reflects a less
severe disease. The follow-up period of the mothers with PPCM was also short. All patients
with confirmed PPCM at presentation received health education about the condition and the
significance of adherence to the prescribed standard heart failure regimen. Early initiation of
optimal anti-failure therapy and good adherence directly translates to favourable clinical
outcomes.
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Varying rates of maternal mortality have been reported in most African studies. This could
probably be due to differences in disease severity at diagnosis (low NYHA functional class and
LVEF) and disparities in clinical management of PPCM during follow-up. Comparable rates
of mortality of patients with PPCM at six months of follow-up were documented in Zimbabwe
(11.6%) [26] and South Africa (10%, 12.6% and 13%) [17, 19, 25]. Higher rates of mortality
were noted at six months of follow-up in Nigeria (24.2%) [11] and at 1 week post hospital dis-
charge in Burkina Faso (48.3%) [22]. Predictors of mortality in the studies conducted in South
Africa were low systolic blood pressure, tachycardia, increased LV end diastolic and systolic
diameter, young age, lower BMI and NYHA functional class [17, 19].
Similar to our study finding, the majority of patients with PPCM do not achieve complete
recovery of LV function as shown in other African studies. In one study of 176 patients with
newly diagnosed PPCM in South Africa, complete recovery of LV function was noted in 21%
of the patients at six months of follow-up [19]. A comparable proportion of patients with com-
plete recovery of LV function was noted in our study (46.3%) and in a study conducted in
Zimbabwe (45.7%) [26].
Study limitations
This study had a short follow-up period of only six months. A longer follow-up period would
have offered more information about maternal and foetal outcomes and their respective pre-
dictors. The study findings might not be representative of the general population because it
was conducted in one tertiary specialised cardiology institution which is located in the capital
city in the central region of Uganda. Despite these limitations, this is the first study to robustly
investigate the burden of PPCM, its predictors and related maternal and foetal outcomes in
Uganda and in Eastern Africa.
Conclusion
PPCM is relatively prevalent in Uganda and is associated with multiple pregnancy gestation.
In this cohort, the majority of the patients with PPCM presented with less severe disease as
reflected by NYHA functional status at baseline and did not achieve full recovery of the LV
function within six months of follow-up. No maternal or foetal mortality was reported.
Larger studies with longer follow-up periods are warranted to further robustly investigate
long term maternal and foetal outcomes in Uganda.
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